Altre lingue Eli Lilly and Company

Azioni

LLY

US5324571083

Prodotti farmaceutici

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 18/02/2026			Preapertura 01:55:06
1.020,56 ^USD	-1,50%		1.026,00	+0,53%

18/02	J&J investirà 1 miliardo di dollari in un nuovo stabilimento in Pennsylvania nell'ambito della spinta manifatturiera negli Stati Uniti	RE
18/02	Eli Lilly and Company annuncia risultati positivi dallo studio TOGETHER-PsO su Taltz (Ixekizumab) e Zepbound (Tirzepatide)	CI

Altre lingue

18/02	Global markets live: Alphabet, Amazon, Microsoft, Palo Alto Networks, DeepMind…
18/02	J&J to invest $1 billion in new Pennsylvania plant amid US manufacturing push
18/02	Wall Street attendue en hausse avant plusieurs statistiques
18/02	Eli Lilly and Company Announces Positive Topline Results from Taltz and Zepbound (Tirzepatide)
18/02	Eli Lilly Says Taltz With Zepbound Deliver 'Superior' Skin Clearance, Weight Loss
18/02	Succès d'un essai de phase III pour la combinaison Taltz-Zepbound (Eli Lilly)
18/02	Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) used together delivered superior efficacy in first-of-its-kind phase 3b trial
18/02	Eli Lilly says Zepbound & Taltz improve psoriasis symptoms, drive weight loss in study
18/02	Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
18/02	Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
18/02	USA-Les valeurs à suivre à Wall Street (actualisé)
18/02	Lurpak-maker Arla sees lower dairy prices and boost from protein products
18/02	Multiples problèmes
18/02	CSL signs licensing deal with Eli Lilly for clazakizumab to explore other potential treatments
18/02	CSL signs licensing deal with Eli Lilly for clazakizumab
18/02	CSL Enters Licensing Deal With Eli Lilly
18/02	Australian shares climb as NAB sets peak, BlueScope jumps on improved bid
17/02	CSL licenses Eli Lilly's clazakizumab to cut cardiac risk in end-stage kidney disease
17/02	CSL and Lilly enter licensing agreement for clazakizumab
17/02	Sector Update: Health Care Stocks Mixed in Late Afternoon Trading
17/02	Sector Update: Health Care Stocks Mixed Tuesday Afternoon
17/02	Sana Biotechnology, Inc. Appoints Brian Piper as Chief Financial Officer
17/02	Sana Biotechnology, Inc. Appoints Brian Piper as Executive Vice President
17/02	Die große KI-Neubewertung
17/02	Integra Lifesciences Holdings Corporation Announces Appointments of Executives

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Filtri

Ultime notizie

Lilly Riduce i Prezzi per gli Acquirenti in Contanti del Farmaco Dimagrante Zepbound

01 dicembre 2025 alle 16:39

Eli Lilly: ingresso in un club molto esclusivo

28 novembre 2025 alle 10:56